Ensign Peak Advisors, Inc Ptc Therapeutics, Inc. Transaction History
Ensign Peak Advisors, Inc
- $55.3 Billion
- Q4 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 208,302 shares of PTCT stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
208,302
Previous 208,302
-0.0%
Holding current value
$10.5 Million
Previous $7.73 Million
21.66%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$393 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$374 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$323 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$242 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.62B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...